Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipatasertib + mFOLFOX6 in Gastric/GEJ Cancer
NCT01896531Phase 2Completed
- Sponsor
- Genentech
- Start
- Aug 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of ipatasertib in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Genentech. Started Aug 2013; status: completed.
02
Drugs
ipatasertib
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01896531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896531.